By Dr Stefanie Vaccher

Conference Posters

Vaccher S; Holt M; Prestage G; Amin J; Selvey C; Zablotska-Manos I; Guy R; Jin F; Carr A; Grulich A; Bavinton B, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c

Vaccher S; Kolstee J; Holt M; Haire B; Prestage G, 2019, 'The social media response to an Australian PrEP seroconversion', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/85842bc72f3443e5a878c2bbb5ea0541

Vaccher S; Guy R; Templeton D; Zablotska-Manos I; Clackett S; Holt M; Prestage G; Amin J; Selvey C; Jin F; Grulich A; Bavinton B, 2019, 'Pre-exposure prophylaxis use among trans and gender diverse people: Characteristics and behaviour from the EPIC-NSW trial', Vancouver, Canada, presented at STI & HIV World Congress, Vancouver, Canada, 14 July 2019

Vaccher S; Grulich A; Haire B; Templeton D; McNulty A; Foster R; Ooi C; Poynten M; Prestage G; Zablotska-Manos I, 2018, 'High adherence to HIV PrEP among clinic attendees over 12 months in the PRELUDE open-label demonstration project', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2018

Vaccher S; Callander D; Maher L; Zablotska-Manos I; Haire B, 2017, '“Breakfast cereal, glass of orange juice and my PrEP”: A qualitative exploration of adherence and non-adherence to daily pre-exposure prophylaxis (PrEP)', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2017

Vaccher S; Marzinke M; Grulich AE; Ooi C; Carr A; Haire BG; Selvey C; Templeton DJ; Holt M; Crooks L; Zablotska I, 2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017, http://programme.ias2017.org/Abstract/Abstract/3358

Vaccher SJ; Grulich A; Prestage G; Bavinton B; Zablotska-Manos I, 2016, 'Use of behavioural eligibility criteria to identify high-HIV risk gay and bisexual men (GBM) for enrolment in a pre-exposure prophylaxis (PrEP) study in NSW, Australia', Durban, South Africa, presented at AIDS 2016, Durban, South Africa, 16 July 2016 - 21 July 2017, http://dx.doi.org/10.26190/unsworks/26284

Vaccher S; Prestage G; McNulty A; Carr A; Holden J; Schmidt H-M; Holt M; Ooi C; Templeton D; Poynten M; Grulich A; Zablotska-Manos I, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015

Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2014, 'Barriers to care in gout: A qualitative study of patients’ and prescribers’ understanding and management', Melbourne, Australia, presented at ASCEPT Scientific Meeting, Melbourne, Australia, 07 December 2014

Back to profile page